PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios

ACADIA Pharmaceuticals Inc. (ACAD)

Equity · Currency in USD · Last updated Oct 4, 2023
SummaryFinancials

Company Info

ISINUS0042251084
CUSIP004225108
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$3.41B
EPS-$0.67
PEG Ratio-0.42
Revenue (TTM)$550.90M
Gross Profit (TTM)$145.49M
EBITDA (TTM)-$124.29M
Year Range$13.73 - $33.99
Target Price$31.13
Short %8.75%
Short Ratio8.79

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of $10,000 in ACADIA Pharmaceuticals Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%20.00%40.00%60.00%80.00%MayJuneJulyAugustSeptemberOctober
13.67%
3.03%
ACAD (ACADIA Pharmaceuticals Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ACAD

ACADIA Pharmaceuticals Inc.

Popular comparisons: ACAD vs. ABT

Return

ACADIA Pharmaceuticals Inc. had a return of 30.53% year-to-date (YTD) and 21.95% in the last 12 months. Over the past 10 years, ACADIA Pharmaceuticals Inc. had an annualized return of -3.21%, while the S&P 500 had an annualized return of 9.51%, indicating that ACADIA Pharmaceuticals Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-25.22%-6.34%
6 months12.45%2.77%
Year-To-Date30.53%9.76%
1 year21.95%14.57%
5 years (annualized)-0.65%7.80%
10 years (annualized)-3.21%9.51%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-9.04%13.34%10.17%1.91%22.09%-7.59%-22.87%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for ACADIA Pharmaceuticals Inc. (ACAD) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ACAD
ACADIA Pharmaceuticals Inc.
0.56
^GSPC
S&P 500
1.05

Sharpe Ratio

The current ACADIA Pharmaceuticals Inc. Sharpe ratio is 0.56. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.00MayJuneJulyAugustSeptemberOctober
0.56
0.92
ACAD (ACADIA Pharmaceuticals Inc.)
Benchmark (^GSPC)

Dividend History


ACADIA Pharmaceuticals Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%MayJuneJulyAugustSeptemberOctober
-63.54%
-12.33%
ACAD (ACADIA Pharmaceuticals Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the ACADIA Pharmaceuticals Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the ACADIA Pharmaceuticals Inc. is 96.29%, recorded on Nov 12, 2010. It took 645 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.29%Mar 17, 20061175Nov 12, 2010645Jun 10, 20131820
-77.18%Jul 8, 2020491Jun 21, 2022
-73.99%Jul 20, 2015777Aug 17, 2018327Dec 5, 20191104
-40.8%Feb 28, 201432Apr 14, 2014161Dec 2, 2014193
-38.42%Dec 9, 201967Mar 16, 202029Apr 27, 202096

Volatility Chart

The current ACADIA Pharmaceuticals Inc. volatility is 21.50%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%MayJuneJulyAugustSeptemberOctober
21.50%
3.35%
ACAD (ACADIA Pharmaceuticals Inc.)
Benchmark (^GSPC)